Role of a quantitative D-dimer assay in determining the need for CT angiography of acute pulmonary embolism

AJR Am J Roentgenol. 2004 Jun;182(6):1377-81. doi: 10.2214/ajr.182.6.1821377.

Abstract

Objective: Our goal was to use the results of a quantitative D-dimer assay to determine the need for pulmonary CT angiography in patients suspected of having acute pulmonary embolism.

Materials and methods: From July 2001 to December 2002, 755 patients underwent pulmonary CT angiography for the evaluation of acute pulmonary embolism. A rapid, fully automated quantitative D-dimer assay was obtained in more than half the patients. The electronic medical records of the patients were subsequently reviewed to analyze the negative predictive value of the D-dimer assay in the diagnostic workup of acute pulmonary embolism and to determine the outcome of the patients who had negative findings on both D-dimer assay and pulmonary CT angiography at 3-month follow-up.

Results: Of the 755 patients who underwent pulmonary CT angiography, 666 (88.2%) had negative findings, 73 (9.7%) had positive findings, and 16 (2.1%) were indeterminate. A total of 426 patients underwent both pulmonary CT angiography and D-dimer level evaluation, and 84 of these had negative findings (< 0.4 microg/mL) on D-dimer assay. Eighty-two of the 84 patients with negative findings on D-dimer assay had negative findings on pulmonary CT angiography; two were indeterminate and both subsequently had low-probability ventilation-perfusion studies. Among patients with positive D-dimer assays, no one with a level between 0.4 and 1.0 microg/mL had pulmonary CT angiography with findings positive for pulmonary embolism.

Conclusion: A quantitative D-dimer assay was effective in excluding the need for pulmonary CT angiography and had high negative predictive value when the D-dimer level was less than 1.0 microg/mL.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiography / methods*
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pulmonary Embolism / blood*
  • Pulmonary Embolism / diagnostic imaging*
  • Retrospective Studies
  • Tomography, X-Ray Computed*

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D